Quality built in, not bolted on
Our quality approach is embedded in every experiment, report, and decision — not added as a final step before delivery.
Documented Development Histories
Documented Development Histories
Every experiment is recorded with purpose, method, results, and conclusions. Development history reports (DHR) are generated throughout your program — not reconstructed at the end. This gives you clear traceability and a defensible record for regulatory review.
Discuss your program →Data Integrity & Traceability
Data Integrity & Traceability
We maintain clear audit trails for all raw data, calculations, and analytical results. Our data management practices align with FDA 21 CFR Part 11 principles and EU GMP Annex 11 expectations — ensuring your data is trustworthy from day one.
Discuss your program →Risk-Based Approach
Risk-Based Approach
We apply ICH Q9 risk management principles to prioritize development and qualification efforts where they matter most — focusing resources on critical quality attributes and process parameters that support a science-based regulatory strategy.
Discuss your program →Development-phase quality for regulatory success
At the development stage, quality means documenting what you did, why you did it, and what it means for your process. ArtProtein ensures every deliverable is structured to support your regulatory filings — from IND CMC through BLA.
Quality you can count on
Let's discuss how our quality approach aligns with your regulatory strategy and timeline.